Merck oral hepatitis C regimen shows 95 pct cure rate

April 24 (Reuters) - Merck and Co Inc presented trial results on Friday showing that a once-daily combination of two experimental pills cured 95 percent of previously untreated hepatitis C patients after 12 weeks.